News Vaxxas announces CEPI partnership to advance needle-free mRN... Biotech Vaxxas has announced a partnership agreement with the 2017-established Coalition for Epidem
R&D Keeping the pandemic at bay with needle-free vaccine deliver... COVID-19 is still circulating and there are fears that further spikes in cases are to be expected in the coming months.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
